glp-1 suicidal ideation Association of glucagon-like peptide-1 receptor agonists with and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study | Diabetologia Evaluating Suicidal Risk in GLP-1RA

Patients taking GLP-1 agonists most commonly complain of gastrointestinal effects, 2 such as unsettled stomach, upset GI tract, variable bowel movements or trouble with elimination, abdominal discomfort, and gastroesophageal discomfort

The session provides an overview of the currently available GLP-1 products for generic products to reference

52 Research supports multiple strategies for consuming adequate protein to preserve or improve muscle mass, including consumption of plant-based proteins and supplementation with branched-chain amino acids or whey protein

18,20 The effects on appearance are often similar to the impact of aging

It can be difficult for consumers to tell the difference or trust the quality of the obesity drugs they're buying